Searchable abstracts of presentations at key conferences in endocrinology

ea0032p774 | Obesity | ECE2013

Diabetes remission after bariatric surgery may be jeopardized by remission criteria and previous hypoglycemic treatment

Ramos-Levi Ana , Sanchez-Pernaute Andres , Cabrerizo Lucio , Matia Pilar , Barabash Ana , Hernandez Carmen , Calle-Pascual Alfonso , Torres Antonio , Rubio Miguel

Introduction: Controversy exists regarding type 2 diabetes (T2D) remission rates after bariatric surgery (BS) due to heterogeneity in its definition and patients’ baseline features. We evaluate T2D remission using recent criteria, according to preoperative characteristics and insulin use.Materials and methods: Retrospective study from a cohort of 657 BS performed in a single centre (2006–2011) of which 141 (57.4% women) had T2D. Evaluation of a...

ea0032p775 | Obesity | ECE2013

Should remission of type 2 diabetes mellitus be the foremost goal after bariatric surgery?

Ramos-Levi Ana , Matia Pilar , Cabrerizo Lucio , Barabash Ana , Sanchez-Pernaute Andres , Hernandez Carmen , Calle-Pascual Alfonso , Torres Antonio , Rubio Miguel

Introduction: Remission of type 2 diabetes (T2D) is a yearned outcome after bariatric surgery (BS). Attention to individuals who do not strictly fulfil remission criteria has been frequently left behind. The aim of this study was to evaluate metabolic control status in patients considered as diabetes ‘non-remitters’.Materials and methods: Retrospective study of 125 patients (59.2% women) with preoperative diagnosis of T2D who underwent BS in a ...

ea0032p1123 | Thyroid cancer | ECE2013

Histopathologic characterization of differentiated thyroid carcinoma in an area of Basque country

Vicente Ma Angeles Vicente , Polo Pilar Sierra , Gomez Carmen Cabrejas , Iregi IzasKun Olaizola , Cabrera Natalia Gonzalez , Gomez Clara Rosario Fuentes , Miguel Ma Angeles Anton

Background: The most common type of thyroid cancer is the well-differentiated thyroid carcinoma (DTC) and that includes papillary (PTC) and follicular carcinoma (FTC). The PTC would represent 50–90% and the FTC over 15–30%. Within the PTC, the most frequent is the classical variant (over 80%), followed by follicular variant (10%) and the rest of variants (<10%). Furthermore, there are differences between PTC and FTC in age at diagnosis, local extension, multicent...

ea0026p454 | Thyroid cancer | ECE2011

Estrogen receptors and progesterone receptor expression and their relationship to types of thyroid cancer

Cameselle-Teijeiro Jose , Alberte-Lista Lara , Peteiro-Gonzalez Diego , Melo Miguel , Abdulkader Ihab , Soares Paula , Gayoso-Diz Pilar , Sobrinho-Simoes Manuel

The role of hormones and reproductive factors in thyroid carcinoma is suggested by its higher incidence in women. The association with estrogens or other specific hormonal factors remains unclear. We assessed the estrogen receptor alpha (ESRa), estrogen receptor beta (ESRb) and progesterone receptor (PRR) expression in follicular cell-derived tumours (FDT).Cross-sectional study of 50 (25%) males, median age 50.5 (interquartile range, IR, 34), and 149 (75...

ea0014p533 | (1) | ECE2007

Effects of glucocorticoid replacement on bone mass in women after long-term remission of Cushing’s syndrome

Barahona Maria-Jose , Sucunza Nuria , Lluch Pilar , Fedrnandez-Real Jose-Manuel , Ricart Wifredo , Puig Teresa , Wäger Ana M , van Elzelingen Caroline , Farrerons Jordi , Webb Susan M

High dose and long-term glucocorticoid (GC) therapy reduce bone mass and negatively affect the metabolic profile. Patients in remission after successful treatment of Cushing’s syndrome (CS) often present hypoadrenalism and require long-term GC replacement.Objective: To evaluate the effect of GC therapy on bone and metabolic parameters in women after long-term remission of CS. Materials and methods: Thirty-two women (mean age: 50±14 years) with ...

ea0056p130 | Endocrine tumours and neoplasia | ECE2018

Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors

Martin-Portugues Antonio Ballesteros , Garcia Maria Isabel del Olmo , Arques Pilar Bello , Huerta Angel Segura , Garcia Juan Antonio Mendez , Torres Juan Francisco Merino

Introduction: The NETTER 1 trial resulted in markedly longer progression-free survival (PFS), with preliminary evidence of an overall survival benefit. We report the results of PFS and safety of (177Lu)-DOTATATE in patients treated in our hospital between 2014 and 2017.Methods: Transversal and descriptive study of 22 patients with advanced, progressive, somatostatin receptor-positive tumors who had received previous treatments. All of them were treated w...

ea0099p60 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Predicting liver fibrosis using artificial intelligence in obese patiens

Penso Rona , Perez Natalia , Matias Pilar , Torres Antonio , Sanchez-Pernaute Andres , Garcia Candela , Crespo Irene , Herraiz Lorea , Elena Mendoza Maria , Angel Rubio Miguel

Introduction: The prevalence of hepatic steatosis in people with obesity is very high. However, what is relevant is to detect those patients with associated fibrosis. The aim of the present study was to predict by artificial intelligence (AI) using clinical-analytical parameters, the presence of liver fibrosis in the biopsy performed during bariatric surgery (BS) of patients with obesity.Subjects and methodology: Cross-sectional study of patients with ob...

ea0081p160 | Pituitary and Neuroendocrinology | ECE2022

Differences in pituitary apoplexy

Biagetti Betina , Isabel Sarria Estrada Silvana , Esteban Cordero-Asanza , Chaachou-Charradi Anas , Ng-Won Karelis , Cicuendez Lopez Ocana Marta , Hernandez-Hernandez Irene , Rojano Toimil Alba , Pilar Costa Forner M , Elena Martinez-Saez , Casteras Anna , Simo Canonge Rafael

Objective: Pituitary apoplexy (PA) is a rare, sometimes life-threatening clinical syndrome. However, some cases are subclinical (SPA), just revealed by MR performed during the follow-up of known pituitary adenomas or due to other conditions. Our aims were to describe the clinical characteristics and evolution of the patients with SPA compared with patients with acute PA (APA). We also compare the results of surgery vs conservative management in the APA group.<p class="abst...

ea0081p178 | Pituitary and Neuroendocrinology | ECE2022

Metastatic pheochromocythoma and paragangliomas: clinical and follow-up characteristics in a reference unit

Giron Giselle , Isabel Del Olmo Garcia Maria , Segura Angel , Prado Stephan , Bello Pilar , Palasi Rosana , Luis Ponce Jose , Lopez Agullo Susana , Gomez-Elegido Tenes Lidia , Francisco Merino Torres Juan

Introduction: Pheochromocytomas(PCC) and paragangliomas(PGGLs) are rare neuroendocrine tumors. Management is very complex, this is why physicians involved in the management of these patients need to take into account not only clinical aspects but also genetics of these tumors. We present a group of patients diagnosed of metastatic PGG or PCC, their characteristics and long term follow-up.Methods and design: Descriptive and unicentric study that includes ...

ea0081ep583 | Endocrine-Related Cancer | ECE2022

Novel peptides and cell lines to expand the tools and models to study the potential of the somatostatin system in NETs

Mangili Federica , Moreno Montilla Maria Trinidad , Salamanca Jimenez Pilar , Garcia Vioque Victor , Encinas Rey Ricardo Blazquez , Alors-Perez Emilia , Mantovani Giovanna , Peverelli Erika , Schrader Jo rg , Ibanez Costa Alejandro , Castano Justo P.

Neuroendocrine tumors (NETs) represent a heterogeneous group of malignancies with increasing incidence worldwide, due in part to enhanced awareness and diagnosis improvements. Surgery is often effective for local disease, whereas disseminated or metastatic disease require pharmacological treatment, which is not always successful. Pancreatic (Pan-NETs) and pulmonary (Lung-NETs) neuroendocrine tumors frequently express somatostatin receptors (SSTs), providing the target for trea...